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Background
Leptospirosis is one of the most common zoonoses in
the world, with a wide range of manifestations that can
vary from mild to severe with acute hepatic and renal
failure, pneumonia or meningitis. Between 2005-2011 in
Romania, according to ECDC, 1740 cases have been
reported. Objective: To describe clinical and laboratory
characteristics of confirmed cases of leptospirosis.
Methods
Retrospective study, between January 2004-June 2014, in
one infectious diseases hospital in Bucharest. We
included patients with leptospirosis diagnosis at dis-
charge and/or positive serology for leptospirosis. Serolo-
gical diagnosis of acute leptospirosis was made by
microscopic agglutination test using a battery of 17 anti-
gens from international reference strains in one national
reference laboratory and/or positive IgM-enzyme-linked
immunosorbent assay (ELISA). Statistical analysis was
performed with SPSS v19.0; continuous variables were
described with medians and ranges; categorical variables
were described with numbers and percentages.
Results
Of 132 patients with leptospirosis diagnosis at discharge,
105 (80%) had positive serology for leptospirosis. The
median age was 37 (IQR 29-53) and 94 (90%) were
male. 71 (68%) patients were diagnosed between May
and September, 54 (51%) lived in urban areas and 8
(8%) patients had professional exposure. Leptospirosis
serotype has been identified in 75 (71%) patients. 9 (9%)
patients had meningeal involvement, 12 (12%) patients
respiratory manifestations, 66 (63%) patients renal
impairment and 38 (36%) patients coagulation impair-
ment. The median level of alanin aminotransferase,
gamma-glutamyl transpeptidase and total bilirubin were
88 IU/mL (IQR 50-158), 162 IU/mL (IQR 86-279) and
4.7 mg/dL (IQR 1.2-14.7), respectively. Leukocytosis
(WBC >10.000/µL) was present in 55 (52%) patients,
severe thrombocytopenia (PLT <50.000/µL) in 25 (24%)
patients and 87 (83%) patients had inflammatory syn-
drome. In-hospital mortality was 4% (4/105).
Conclusion
Liver and renal failure were the most common manifes-
tations in leptospirosis. Increased awareness should be
maintained in order to diagnose and initiate early ade-
quate treatment to reduce mortality and morbidity.
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